Iradimed (IRMD) Enterprise Value (2016 - 2025)
Iradimed (IRMD) has disclosed Enterprise Value for 13 consecutive years, with -$56.5 million as the latest value for Q3 2025.
- On a quarterly basis, Enterprise Value fell 9.29% to -$56.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$56.5 million, a 9.29% decrease, with the full-year FY2024 number at -$52.2 million, down 4.97% from a year prior.
- Enterprise Value was -$56.5 million for Q3 2025 at Iradimed, down from -$53.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$42.8 million in Q1 2023 to a low of -$62.5 million in Q4 2021.
- A 5-year average of -$52.1 million and a median of -$52.2 million in 2022 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: decreased 20.25% in 2021, then rose 16.04% in 2023.
- Iradimed's Enterprise Value stood at -$62.5 million in 2021, then grew by 7.26% to -$58.0 million in 2022, then increased by 14.15% to -$49.8 million in 2023, then dropped by 4.97% to -$52.2 million in 2024, then decreased by 8.22% to -$56.5 million in 2025.
- Per Business Quant, the three most recent readings for IRMD's Enterprise Value are -$56.5 million (Q3 2025), -$53.0 million (Q2 2025), and -$50.3 million (Q1 2025).